Antidiabetics

Global Antidiabetics Market: Global Market Size, Trends, Competitive, Historical & Forecast Analysis, 2019-2025

Report ID: BMRC 530 | Number of pages: 188 | Publish Date: Jul 2019 | Category: Lifesciences and Healthcare
Global Antidiabetics Market is valued at USD 67.28 Billion in 2018 and expected to reach USD 132.79 Billion by 2025 with the CAGE of 10.2% over the forecast period. Rising incidences of diabetes, changing lifestyle and growing R&D activities are some of the factors driving the growth of the Global Antidiabetics Market.

Antidiabetics is commonly used to manage diabetes with the help of antidiabetic agent. It helps a person with diabetes, to control their level of glucose (sugar) in the blood. It mainly includes insulin and the oral hypoglycemic agents. There are different classes of anti-diabetic drugs and their selection depends on the nature of the diabetes, age and situation of the person, as well as on some other factors. Antidiabetic agents denote to all the different types of medicine involved in the treatment of diabetes. All these agents aim to reduce blood sugar levels to an acceptable range (called achieving normoglycemia) and relieve symptoms of diabetes such as thirst, excessive urination, and ketoacidosis (a serious complication of diabetes that occurs when the body cannot use glucose as a fuel source).

Global antidiabetics market report is segmented on the basis of product, drug class, route of administration and regional & country level. Based on product global antidiabetics market is classified as rapid acting insulin, long acting insulin, premixed insulin, short acting insulin, and intermediate acting insulin. Based upon drug class, global antidiabetics market is classified into alpha-glucosidase inhibitors, biguanides, sulphonylureas, GLP-1 agonist, meglitinides, DPP-4 inhibitors, sglt-2, and thiazolidinedione. Based upon route of administration, global antidiabetics market is classified as insulin syringe/insulin pen, insulin pump, intravenous infusion, and oral.

Key Players for Global Antidiabetics Market Report-
Global antidiabetics market report covers prominent players like Eli Lilly, Novartis, Bayer Corporation, Johnson & Johnson, Pfizer, AstraZeneca, Bristol-Myers Squibb, Oramed Pharmaceuticals, Novo Nordisk, Merck, Boehringer Ingelheim, Takeda Pharmaceutical, Sanofi, and others.

Scope Of The Report:
Report evaluates the growth rate and the Market value based on Market dynamics, growth inducing factors. The complete knowledge is based on latest industry news, opportunities and trends. The report contains a comprehensive Market analysis and vendor landscape in addition to a SWOT analysis of the key vendors.
Geographically, this report split global into several key Regions, revenue (Million USD) The geography (North America, Europe, Asia-Pacific, Latin America and Middle East & Africa) focusing on key countries in each region. It also covers market drivers, restraints, opportunities, challenges, and key issues in Global Antidiabetics Market. 

Key Benefits for Antidiabetics Market Reports 
• Global market report covers in-depth historical and forecast analysis.
• Global market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market Opportunities, Competitive Analysis, Regional and Country Level.
• Global market report helps to identify opportunities in market place.
• Global market report covers extensive analysis of emerging trends and competitive landscape.

Global Antidiabetics Market Segmentation:–
By Product:
•	Rapid Acting Insulin 
•	Long Acting Insulin
•	Premixed Insulin
•	Short Acting Insulin
•	Intermediate Acting Insulin
By Drug Class:
•	Alpha-Glucosidase Inhibitors
•	Biguanides, Sulphonylureas
•	GLP-1 Agonist
•	Meglitinides
•	DPP-4 Inhibitors 
•	SGLT-2
•	Thiazolidinedione
By Route of Administration:
•	Insulin Syringe/Insulin Pen
•	Insulin Pump
•	Intravenous Infusion
•	Oral
By Regional & Country Analysis:
•	North America
o	U.S.
o	Mexico
o	Canada 
•	Europe
o	UK
o	France
o	Germany
o	Italy 
•	Asia Pacific
o	China
o	Japan
o	India
o	Southeast Asia
•	Latin America
o	Brazil
•	The Middle East and Africa
o	GCC
o	Africa
o	Rest of Middle East and Africa


This comprehensive report will provide:
• Enhance your strategic decision making
• Assist with your research, presentations and business plans
• Show which emerging market opportunities to focus on
• Increase your industry knowledge
• Keep you up-to-date with crucial market developments
• Allow you to develop informed growth strategies
• Build your technical insight
• Illustrate trends to exploit
• Strengthen your analysis of competitors
• Provide risk analysis, helping you avoid the pitfalls other companies could make
• Ultimately, help you to maximize profitability for your company.
Our Market Research Solution Provides You Answer to Below Mentioned Question:
• Which are the driving factors responsible for the growth of market?
• Which are the roadblock factors of this market?
• What are the new opportunities, by which market will grow in coming years?
• What are the trends of this market?
• Which are main factors responsible for new product launch?
• How big is the global & regional market in terms of revenue, sales and production?
• How far will the market grow in forecast period in terms of revenue, sales and production?
• Which region is dominating the global market and what are the market shares of each region in the overall market in 2017?
• How will each segment grow over the forecast period and how much revenue will these segment account for in 2025?
• Which region has more opportunities?
Interested in this report?
Get your sample now!
Table of Content
1. Chapter - Report Methodology
1.1. Research Process 
1.2. Primary Research 
1.3. Secondary Research
1.4. Market Size Estimates
1.5. Data Triangulation
1.6. Forecast Model 
1.7. USP’s of Report 
1.8. Report Description 
2. Chapter – Global Antidiabetics Market Overview: Qualitative Analysis
2.1. Market Introduction
2.2. Executive Summary 
2.3. Global Antidiabetics Market Classification
2.4. Market Drivers
2.5. Market Restraints
2.6. Market Opportunity
2.7. Antidiabetics Market: Trends
2.8. Porter’s Five Forces Analysis
2.8.1. Bargaining Power of Suppliers
2.8.2. Bargaining Power of Consumers
2.8.3. Threat of New Entrants
2.8.4. Threat of Substitute Product and Services
2.8.5. Competitive Rivalry within the Industry
2.9. Market Attractiveness Analysis 
2.9.1. Market Attractiveness Analysis by Segmentation 
2.9.2. Market Attractiveness Analysis by Region 
3. Chapter - Global Antidiabetics Market Overview: Quantitative Analysis
3.1. Global Antidiabetics Market Revenue (USD Million), Market Share (%) and Growth Rate (%), 2014- 2025
3.2. Global Antidiabetics Market Revenue Market Share (%), 2014- 2025
3.3. Global Antidiabetics Market Sales (Number of Units), Market Share (%) and Growth Rate (%), 2014- 2025
3.4. Global Antidiabetics Market Sales Market Share (%), 2014- 2025
4. Chapter – Global Antidiabetics Market Analysis: By Type
5. Chapter – Global Antidiabetics Market Analysis: By Applications
6. Chapter – Global Antidiabetics Market Analysis: By End-User Type
7. Chapter - Global Antidiabetics Market Analysis: By Manufacture
7.1. Global Antidiabetics Market Revenue (USD Million), by Manufacturer, 2014 - 2025
7.2. Global Antidiabetics Market Share (%), by Manufacturer, 2018
7.3. Global Antidiabetics Market Sales (Number of Units), by Manufacturer, 2014 - 2025
7.4. Global Antidiabetics Market Share (%), by Manufacturer, 2018
7.5. Global Antidiabetics Market Price (USD/Unit), by Manufacturer, 2014 - 2025
7.6. Global Antidiabetics Market Revenue Growth Rate (%), by Manufacturer, 2014 – 2025
7.7. Merger & Acquisition
7.8. Collaborations and Partnership
7.9. New Product Launch
8. Chapter –Antidiabetics Market: Regional Analysis
8.1. North America
8.1.1. North America Antidiabetics Market Revenue (USD Million) and Growth Rate (%), 2014 – 2025.
8.1.2. North America Antidiabetics Market Revenue (USD Million) By Country, 2014 – 2025.
8.1.3. North America Antidiabetics Revenue Market Share (%) By Country, 2014 – 2025.
8.1.4. North America Antidiabetics Market Revenue (USD Million) and Growth Rate, By Market Segmentation, 2014 – 2025.
8.1.5. North America Antidiabetics Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2014 – 2025.
8.1.6. North America Antidiabetics Market Sales (Number of Units) and Growth Rate (%), 2014 – 2025.
8.1.7. North America Antidiabetics Market Sales (Number of Units) By Country, 2014 – 2025.
8.1.8. North America Antidiabetics Sales Market Share (%) By Country, 2014 – 2025.
8.1.9. North America Antidiabetics Market Sales (Number of Units) and Growth Rate, By Market Segmentation, 2014 – 2025.
8.1.10. North America Antidiabetics Market Sales (Number of Units), Market Share (%) and Growth Rate, By Market Segmentation, 2014 – 2025.
8.2. Europe
8.3. Asia Pacific
8.4. Latin America
8.5. Middle East & Africa
9. Chapter - Company Profiles
9.1. Astra Zeneca 
9.1.1. Financials
9.1.2. Product portfolio
9.1.3. Antidiabetics Market Revenue (USD Million) and Market Share (%), 2014 - 2018
9.1.4. Antidiabetics Sales Market Share (%), 2014 - 2018
9.1.5. Business strategy
9.1.6. Recent developments
9.2. Astra Zeneca 
9.3. Boehringer Ingelheim 
9.4. Eli Lilly 
9.5. Johnson & Johnson 
9.6. Merck 
9.7. Novartis 
9.8. Novo Nordisk 
9.9. Sanofi 
9.10. Teva Pharmaceutical Industries 
9.11. Others. 
10. Chapter – Market Research and Findings